Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

被引：0

作者：

Cliff Molife

Katherine B. Winfree

Hollie Bailey

Yulia D’yachkova

Cameron Forshaw

Sangmi Kim

Kaisa-Leena Taipale

Tarun Puri

机构：

[1] Eli Lilly and Company,Value, Evidence, and Outcomes

[2] Lilly Corporate Center,Oncology

[3] Adelphi Real World,Lilly International Medical Affairs Oncology

[4] Statistics,undefined

[5] Eli Lilly and Company,undefined

[6] Global Patient Safety-Pharmacoepidemiology,undefined

[7] Eli Lilly and Company,undefined

[8] Value,undefined

[9] Evidence,undefined

[10] and Outcomes-International,undefined

[11] Eli Lilly and Company,undefined

[12] Eli Lilly and Company,undefined

来源：

Advances in Therapy | 2023年 / 40卷

关键词：

Advanced non-small cell lung cancer; Disease Specific Programme™; mutation; Patient-reported outcomes; Point-in-time; Real-world; Survey; Treatment patterns;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3135 / 3168

页数：33

共 50 条

[31] Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer [J].

Satoshi Igawa ;

Taihei Ono ;

Masashi Kasajima ;

Seiichiro Kusuhara ;

Sakiko Otani ;

Tomoya Fukui ;

Masanori Yokoba ;

Masaru Kubota ;

Masato Katagiri ;

Hisashi Mitsufuji ;

Jiichiro Sasaki ;

Katsuhiko Naoki .

Investigational New Drugs, 2020, 38 :1906-1914

[32] A real-world study of dacomitinib in later-line settings for advanced non-small cell lung cancer patients harboring EGFR mutations [J].

Li, Hong-Shuai ;

Zhang, Jin-Yao ;

Yan, Xiang ;

Xu, Hai-Yan ;

Hao, Xue-Zhi ;

Xing, Pu-Yuan ;

Wang, Yan .

CANCER MEDICINE, 2022, 11 (04) :1026-1036

[33] Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational study: a brief report [J].

Kiiskinen, Urpo ;

Segall, Grace ;

Bailey, Hollie ;

Forshaw, Cameron ;

Puri, Tarun .

FRONTIERS IN ONCOLOGY, 2025, 15

[34] Real-world outcomes in patients with KRAS G12C-mutated advanced non-small cell lung cancer treated with docetaxel in second-line or beyond [J].

Gray, Jhanelle E. ;

Hsu, Hil ;

Younan, Diana ;

Suri, Gaurav ;

Chia, Victoria ;

Spira, Alexander ;

Johnson, Melissa .

LUNG CANCER, 2023, 181

[35] Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice [J].

Brueckl, Wolfgang M. ;

Reck, Martin ;

Griesinger, Frank ;

Schaefer, Harald ;

Kortsik, Cornelius ;

Gaska, Tobias ;

Rawluk, Justyna ;

Krueger, Stefan ;

Kokowski, Konrad ;

Budweiser, Stephan ;

Ficker, Joachim H. ;

Hoffmann, Christopher ;

Schueler, Andrea ;

Laack, Eckart .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13

[36] Real-world outcomes in patients with unresected stage III non-small cell lung cancer [J].

Kellie J. Ryan ;

Karen E. Skinner ;

Ancilla W. Fernandes ;

Rajeshwari S. Punekar ;

Melissa Pavilack ;

Mark S. Walker ;

Noam A. VanderWalde .

Medical Oncology, 2019, 36

[37] Real-world outcomes in patients with unresected stage III non-small cell lung cancer [J].

Ryan, Kellie J. ;

Skinner, Karen E. ;

Fernandes, Ancilla W. ;

Punekar, Rajeshwari S. ;

Pavilack, Melissa ;

Walker, Mark S. ;

VanderWalde, Noam A. .

MEDICAL ONCOLOGY, 2019, 36 (03)

[38] Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer [J].

Leighl, Natasha B. ;

Karaseva, Nina ;

Nakagawa, Kazuhiko ;

Cho, Byoung-Chul ;

Gray, Jhanelle E. ;

Hovey, Tina ;

Walding, Andrew ;

Ryden, Anna ;

Novello, Silvia .

EUROPEAN JOURNAL OF CANCER, 2020, 125 :49-57

[39] Real-world treatment patterns and outcomes for patients with non-metastatic non-small cell lung cancer: retrospective analyses in Canada, England, and Germany [J].

Alastair Greystoke ;

Melinda J. Daumont ;

Caroline Rault ;

Hannah Baltus ;

Philip Q. Ding ;

Gabrielle Emanuel ;

Stefano Lucherini ;

Lien Vo ;

Valeria M. Saglimbene ;

Eleanor Ralphs ;

Cátia Leal ;

Minouk J. Schoemaker ;

Alexander Katalinic ;

Annika Waldmann ;

Winson Y. Cheung .

BMC Pulmonary Medicine, 25 (1)

[40] EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects [J].

Soria, Jean-Charles ;

Mok, Tony S. ;

Cappuzzo, Federico ;

Jaenne, Pasi A. .

CANCER TREATMENT REVIEWS, 2012, 38 (05) :416-430

← 1 2 3 4 5 →